Literature DB >> 7657808

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

M S Jacewicz1, D W Acheson, M Mobassaleh, A Donohue-Rolfe, K A Balasubramanian, G T Keusch.   

Abstract

Differentiated villus intestinal epithelial cells express globotriaosylceramide, the Shiga-like toxin 1 (SLT-1) receptor, and are sensitive to toxin-mediated cytotoxicity, whereas undifferentiated crypt cells neither express Gb3 nor respond to toxin. To investigate if SLT-1 receptors are maturationally regulated in human intestinal cells, we examined the effect of butyrate, a known transcriptional regulator of differentiation genes in many cell types, using cultured colonic cancer-derived epithelial cell lines. Exposure to butyrate increased villus cell marker enzymes such as alkaline phosphatase, sucrase, and lactase, expression of toxin receptors, and sensitivity to SLT-1 in villus-like CaCo-2A and HT-29 cells. These effects were reversibly inhibited by preincubation of CaCo-2A cells with actinomycin D or cycloheximide. Butyrate-treated CaCo-2A cells unable to bind fluoresceinated SLT-1 B subunit were undifferentiated as assessed by alkaline phosphatase activity. HT-29 cells induced to differentiate by another signal, glucose deprivation, upregulated receptor content and response to toxin. Crypt-like T-84 cells responded to butyrate with a modest increase in alkaline phosphatase and toxin binding, but no induction of sucrase or lactase, and no change in sensitivity to toxin. The results demonstrate that expression of SLT-1 toxin receptors and toxin sensitivity are coregulated with cellular differentiation in cultured intestinal cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657808      PMCID: PMC185755          DOI: 10.1172/JCI118168

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Morphological and biochemical differentiation in HeLa cells. Effects of cycloheximide on butyrate-induced process formation and ganglioside metabolism.

Authors:  R C Henneberry; P H Fishman
Journal:  Exp Cell Res       Date:  1976-11       Impact factor: 3.905

2.  Suppression of histone deacetylation in vivo and in vitro by sodium butyrate.

Authors:  L C Boffa; G Vidali; R S Mann; V G Allfrey
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

3.  A one-step ultramicro method for the assay of intestinal disaccharidases.

Authors:  M Messer; A Dahlqvist
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

4.  A human colonic tumor cell line that maintains vectorial electrolyte transport.

Authors:  K Dharmsathaphorn; J A McRoberts; K G Mandel; L D Tisdale; H Masui
Journal:  Am J Physiol       Date:  1984-02

5.  Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines.

Authors:  Y S Chung; I S Song; R H Erickson; M H Sleisenger; Y S Kim
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

6.  Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine.

Authors:  M Mobassaleh; O Koul; K Mishra; R H McCluer; G T Keusch
Journal:  Am J Physiol       Date:  1994-10

7.  Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.

Authors:  C Augeron; C L Laboisse
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

8.  DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts.

Authors:  M I Parker; J B de Haan; W Gevers
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

9.  Induction by butyrate of differentiated properties in cloned murine rhabdomyosarcoma cells.

Authors:  D L Dexter; S F Konieczny; J B Lawrence; M Shaffer; P Mitchell; J R Coleman
Journal:  Differentiation       Date:  1981       Impact factor: 3.880

10.  Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

Authors:  A Donohue-Rolfe; G T Keusch; C Edson; D Thorley-Lawson; M Jacewicz
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  24 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Cl(-) secretion in colonic epithelial cells induced by the vibrio parahaemolyticus hemolytic toxin related to thermostable direct hemolysin.

Authors:  A Takahashi; N Kenjyo; K Imura; Y Myonsun; T Honda
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 3.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

4.  T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis.

Authors:  J P Nataro; S Hicks; A D Phillips; P A Vial; C L Sears
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

Authors:  F B Taylor; V L Tesh; L DeBault; A Li; A C Chang; S D Kosanke; T J Pysher; R L Siegler
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 6.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

7.  The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.

Authors:  Tania N Petruzziello-Pellegrini; Darren A Yuen; Andrea V Page; Sajedabanu Patel; Anna M Soltyk; Charles C Matouk; Dennis K Wong; Paul J Turgeon; Jason E Fish; J J David Ho; Brent M Steer; Vahid Khajoee; Jayesh Tigdi; Warren L Lee; David G Motto; Andrew Advani; Richard E Gilbert; S Ananth Karumanchi; Lisa A Robinson; Phillip I Tarr; W Conrad Liles; James L Brunton; Philip A Marsden
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

8.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

Authors:  A Puri; P Hug; K Jernigan; J Barchi; H Y Kim; J Hamilton; J Wiels; G J Murray; R O Brady; R Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.

Authors:  Dong-Oh Moon; Se-Rim Choi; Chang-Min Lee; Gi-Young Kim; Hee-Jeong Lee; Yeong-Min Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.